Universal Multi–Mill Glovebox - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Universal Multi-Mill Glovebox

The Universal Multiple Mill Glovebox for Multiple Mill Systems is part of the Contained Powder Handling product range from original pioneers of high containment technology Powder Systems Limited. PSL’s multiple mill isolator can accommodate different mills in a single glovebox.

A specially designed L-shape window glovebox for inert milling provides product and operator protection, with good access for changing, stripping and cleaning mills within the glovebox. PSL’s Milling Isolator features a lift-up window  for enhanced viewing and ergonomics.

Contained milling process gives an enhanced operator viewing, ergonomics and an assured explosion protection system.

The Universal Multiple Mill Glovebox offers the advantage of a nitrogen-purged environment, nanogram containment, a small area to clean and better control over cross-contamination.

PSL’s universal Milling Isolator is the optimum solution when multiple mills, micronizers or air jet mills are required for a single product or process. Suitable from lab scale to complete facility requirements for manufacturing formulation.

PSL has extensive global experience in contained milling and is an original pioneer of high containment technology. Established for 25 years, PSL provide a full range of high containment solutions for applications including: dispensing and sampling, charging, drum filling, off-loading, sieving and tray drying.

Company name:  Powder Systems Limited

Website: www.powdersystems.com/milling.html         

E-mail: marketing@powdersystems.com

 

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
FindPharma Custom Search

Click here